ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,793Medicare Part D Prescriptions Filled, Including Refills

Rank: 168 out of 1155

$384K Total Retail Price of All Prescriptions

Rank: 123 out of 1155

267 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 267 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

16% of this provider’s 267 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

3% of this provider’s 5,565 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
SIMVASTATIN 374 322 1 3
LEVOTHYROXINE SODIUM 266 244 2 2
LISINOPRIL 215 173 3 1
HYDROCODONE-ACETAMINOPHEN 168 143 S3 4 4
CITALOPRAM HBR 162 136 5 19
OMEPRAZOLE 161 132 6 5
FUROSEMIDE 138 119 7 8
ZOLPIDEM TARTRATE 130 106 8 21
METFORMIN HCL 125 87 9 7
HYDROCHLOROTHIAZIDE 116 107 10 9
RISPERIDONE 103 103 11 73
AMLODIPINE BESYLATE 101 99 12 6
METHADONE HCL 92 48 S2 13 50
AMITRIPTYLINE HCL 91 56 R 14 42
OXYCODONE-ACETAMINOPHEN 89 49 S2 15 45
METOPROLOL TARTRATE 83 65 16 14
DONEPEZIL HCL 82 82 17 41
ATENOLOL 76 62 18 10
GABAPENTIN 72 61 19 15
TAMSULOSIN HCL 67 61 20 27
FLUTICASONE PROPIONATE 67 54 20 37
WARFARIN SODIUM 66 50 22 11
ATORVASTATIN CALCIUM 60 48 23 12
TRAZODONE HCL 60 59 23 22
LISINOPRIL-HYDROCHLOROTHIAZIDE 60 39 23 26
ALLOPURINOL 59 59 26 29
SERTRALINE HCL 57 34 27 24
GLIMEPIRIDE 56 44 28 43
PAROXETINE HCL 55 48 29 48
ALENDRONATE SODIUM 54 54 30 25
FENTANYL 54 20 S2 30 64
METOPROLOL SUCCINATE 53 53 32 17
CLONIDINE HCL 53 40 32 69
LOVASTATIN 51 51 34 13
CYCLOBENZAPRINE HCL 51 29 R 34 38
ESTRADIOL 50 39 R 36 60
TRAMADOL HCL 50 37 36 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 17, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.